PT3595660T - Compostos para utilização na prevenção e/ou tratamento de doença do fígado gordo não-alcoólico e esteato-hepatite nãoalcoólica - Google Patents
Compostos para utilização na prevenção e/ou tratamento de doença do fígado gordo não-alcoólico e esteato-hepatite nãoalcoólicaInfo
- Publication number
- PT3595660T PT3595660T PT187094826T PT18709482T PT3595660T PT 3595660 T PT3595660 T PT 3595660T PT 187094826 T PT187094826 T PT 187094826T PT 18709482 T PT18709482 T PT 18709482T PT 3595660 T PT3595660 T PT 3595660T
- Authority
- PT
- Portugal
- Prior art keywords
- alcoholic
- prevention
- compounds
- treatment
- liver disease
- Prior art date
Links
- 230000001476 alcoholic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 208000019423 liver disease Diseases 0.000 title 1
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 title 1
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762471105P | 2017-03-14 | 2017-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3595660T true PT3595660T (pt) | 2023-09-25 |
Family
ID=61599096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT187094826T PT3595660T (pt) | 2017-03-14 | 2018-02-19 | Compostos para utilização na prevenção e/ou tratamento de doença do fígado gordo não-alcoólico e esteato-hepatite nãoalcoólica |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10857136B2 (pt) |
| EP (1) | EP3595660B1 (pt) |
| JP (2) | JP7343902B2 (pt) |
| CA (1) | CA3053059C (pt) |
| DK (1) | DK3595660T3 (pt) |
| ES (1) | ES2949940T3 (pt) |
| PT (1) | PT3595660T (pt) |
| WO (1) | WO2018166756A1 (pt) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004093871A1 (en) | 2003-03-27 | 2004-11-04 | Lankenau Institute For Medical Research | Novel methods for the treatment of cancer |
| GB2440908A (en) | 2006-05-25 | 2008-02-20 | Intercytex Ltd | Tissue Repair and Augmentation |
| PE20100156A1 (es) | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
| CN107652283B (zh) | 2011-03-28 | 2021-07-06 | Sjt分子研究有限公司 | 用于代谢综合征的治疗的化合物 |
| DK2870970T3 (en) | 2012-04-27 | 2018-05-28 | Toru Miyazaki | PROPHYLACTIC OR THERAPEUTIC AGENTS FOR HEALTH DISEASES |
| JP2016526014A (ja) | 2013-04-24 | 2016-09-01 | アルモ・バイオサイエンシーズ・インコーポレイテッド | インターロイキン−１０組成物及びその使用 |
| US10422786B2 (en) | 2013-12-10 | 2019-09-24 | The Regents Of The University Of California | Differential diagnosis of liver disease |
| US20150342943A1 (en) | 2014-06-03 | 2015-12-03 | Gilead Sciences, Inc. | Methods of treating liver disease |
-
2018
- 2018-02-19 PT PT187094826T patent/PT3595660T/pt unknown
- 2018-02-19 JP JP2019544044A patent/JP7343902B2/ja active Active
- 2018-02-19 DK DK18709482.6T patent/DK3595660T3/da active
- 2018-02-19 CA CA3053059A patent/CA3053059C/en active Active
- 2018-02-19 EP EP18709482.6A patent/EP3595660B1/en active Active
- 2018-02-19 ES ES18709482T patent/ES2949940T3/es active Active
- 2018-02-19 US US16/490,670 patent/US10857136B2/en active Active
- 2018-02-19 WO PCT/EP2018/053990 patent/WO2018166756A1/en unknown
-
2023
- 2023-04-28 JP JP2023075123A patent/JP2023106431A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200016129A1 (en) | 2020-01-16 |
| DK3595660T3 (da) | 2023-09-18 |
| ES2949940T3 (es) | 2023-10-04 |
| JP2023106431A (ja) | 2023-08-01 |
| CA3053059A1 (en) | 2018-09-20 |
| EP3595660A1 (en) | 2020-01-22 |
| EP3595660B1 (en) | 2023-07-05 |
| US10857136B2 (en) | 2020-12-08 |
| WO2018166756A1 (en) | 2018-09-20 |
| CA3053059C (en) | 2023-11-07 |
| JP2020510001A (ja) | 2020-04-02 |
| JP7343902B2 (ja) | 2023-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277648A (en) | Medical microbiota for the treatment and/or prevention of food allergy | |
| HK1249847A1 (zh) | 用於治療非酒精性脂肪肝疾病和/或脂肪營養不良的方法 | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| IL273550A (en) | Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the I148M variant of PNPLA3 | |
| IL290150A (en) | Compounds and methods for treating chronic pain | |
| IL268502A (en) | Triple combination preparations and methods for treating heart disease or reducing its risk | |
| IL274578A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| EP3518918A4 (en) | METHOD AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | |
| HK1257583A1 (zh) | 預防和治療脂肪代謝紊亂及其相關病症的藥物及其用途 | |
| HK1257589A1 (zh) | 預防和治療組織器官纖維化的藥物及其用途 | |
| GB201519557D0 (en) | Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions | |
| IL271236A (en) | Licofligozin for the treatment of non-alcoholic steatohepatitis | |
| IL272097A (en) | Compounds for the prevention and treatment of medical disorders and their uses | |
| HK1258999A1 (zh) | 用於治療肝臟和維持肝臟健康的組合物、方法和藥物組合物 | |
| EP3518951C0 (en) | COMPOSITIONS FOR USE IN THE TREATMENT OF OSTEOPOROSIS AND Fractures | |
| IL272495A (en) | Pharmaceutical compounds and preparations thereof for use in the treatment of leiftic diseases | |
| SG11201704430SA (en) | Preventive and/or therapeutic agent of immune disease | |
| EP3716975A4 (en) | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | |
| EP3718552A4 (en) | APPROPRIATE DRUG COMBINATION FOR THE TREATMENT AND PREVENTION OF NON-ALCOHOLIC HEPATIC STEATOSIS (NAFLAD) AND / OR NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND / OR HEPATIC STEATOSIS | |
| EP3400025C0 (en) | USE OF GAIACOL FOR THE PREVENTION AND TREATMENT OF GLYCOGENOSES | |
| PT3595660T (pt) | Compostos para utilização na prevenção e/ou tratamento de doença do fígado gordo não-alcoólico e esteato-hepatite nãoalcoólica | |
| PT3191112T (pt) | Compostos de dipeptidilcetoamida e sua utilização para o tratamento e/ou prevenção da acumulação de gordura | |
| IL265911A (en) | Epilimod preparations and methods of using them in the treatment of Alzheimer's disease | |
| ZA201706986B (en) | Compositions for the treatment of kidney and/or liver disease | |
| EP3720449C0 (en) | COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF SALMONELLOSIS |